Pediatric multisystem inflammatory syndrome associated with Sars-Cov-2: case report
Main Article Content
Abstract
Introduction: Covid-19 infection begun in China in 2019 spread quickly throughout the world, reaching mainly adults and elderly. In April 2020, however, a multissistemic inflammatory syndrome (MIS-C) with a predominance in children and adolescents was identified. This syndrome manifests in different ways, and may resemble Kawasaki syndrome and toxic shock, and evolve to shock, most cardiogenic, with elevation of cardiac muscle enzymes. Objective: To report the case of two children infected by SARS-COV-2 virus that have evolved with mis-C and reflect on the importance of early and rapid recognition of treatment for illness. Case Description: This is a case report of two distinct patients who presented MIS-C after contracting the SARS-COV-2 virus. The two cases presented different symptoms and evolutions, although both fill diagnostic criteria for the syndrome. Discussion: Among the clinical criteria of MISC, there are more frequently manifestations such as fever, gastrointestinal symptoms, cardiac commitment and elevation of inflammatory markers. In the case of a new syndrome related to CUVD-19, it is of great relevance the documentation of new cases for the best recognition and management of the complication that mainly affects the pediatric age group.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
1. Nakra NA, Blumberg DA, Guerra AH, Guerra S. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management. Children 2020, 7, 69.
2. Makvandi S, Alibrahim O, Avdul-Aziz R, Sallam MAF, McGreevy M. A Rare Presentation of Multi-System Inflammatory Disease in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). 2020.
3. Sáfadi,Marco Aurélio Palazzi; SILVA, Clovis Artur Almeida, et al. Síndrome inflamatória multissistêmica em crianças e adolescentes provavelmente associada à COVID-19: uma apresentação aguda, grave e potencialmente fatal: Sociedade Brasileira de Pediatria. 2020
4. Berezin, Eitan N. SÍNDROME INFLAMATÓRIA MULTISSISTÊMICA PEDIÁTRICA (Síndrome associada temporalmente ao COVID-19) São Paulo; SPSP - Sociedade de Pediatria de São Paulo. 2020.
5. Campos, Leonardo Rodrigues; CARDOSO Tainá Maia; et al. Síndrome inflamatória multissistêmica pediátrica (MIS C) temporariamente associada ao SARS-CoV-2Pediatric inflammatory multisystem syndrome (PIMS) temporally related to SARS-CoV-2: Residência Pediátrica. 2020
6. Jiang L, Tang K, Levin M, Irfan O. COVID-19 and multisystem inflammatory sundrome in children and adolescentes. Elsevier. 2020
7. Ministério da Saúde, Secretaria de Vigilância em Saúde. Síndrome inflamatória multissistêmica pediátrica (SIM-P), temporalmente associada à Covid-19. Boletim Epidemiológico. 2020 Outubro; 51.
8. Sociedade Brasileira de Pediatria. Síndrome inflamatória multissistêmica em crianças e adolescentes provavelmente associada à COVID-19: uma apresentação aguda, grave e potencialmente fatal. 2020
9. Ministério da Saúde. Secretaria de Vigilância em Saúde, Departamento de Imunização e Doenças Transmissíveis, Coordenação-Geral do Programa Nacional de Imunizações. Nota Técnica n. 16/2020-CGPNI/DEIDT/SVS/MS. 2020 Julho 27
10. Sperotto F, Friedman KG, Son MBF, VanderPluym CJ, al JWNe. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. European Journal of Pediatrics. 2021; p. 307-322.
11. Radia T, Williams N, Agrawal P, Harman K, at JWe. Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation. Paediatric Respiratory Reviews. 2020.
12. Kabeerdoss J, Pilania RK, Karkhele R, Kumar TS, at DDe. Severe COVID 19, multisystem infammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical. Rheumatology International. 2020; p. 1-14.
13. Campos LR, Cardoso TM, Martinez JCdFF, Almeida RGd, Silva RM, Fonseca AR, et al. Sindrome inflamatória multissistêmica pediatrica (MIS-C) temporariamnete associada ao SARS-CoV-2. Residência Pediàtrica. 2020
14. Wu, Di; Wu, Tiantian; Liu, Qun; Yang, Zhicong; et al. The SARS-CoV-2 outbreak: what we know; International Journal of Infectious Diseases, 2020.
15. Tang Y, Li W, Baskota M, Zhou Q, al ZFe. Multisystem inflammatory syndrome in children during the coronavirus disease 2019 (COVID-19) pandemic: a systematic review of published case studies. Translation Pediatrics. 2021; p. 121-135
16. Radia T, Williams N, Agrawal P, Harman K, Weale J, Cook J, et al. Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation. Elsevier. 2020 Agosto.
17. Martins, Gabriele Maria Viana, et al: SÍNDROME INFLAMATÓRIA MULTISSISTÊMICA PEDIÁTRICA ASSOCIADA AO COVID-19: Revista Cienfica da FMC. Vol. 15, nº 3, 2020.
18. Lima, Danele Azevedo; et al; A síndrome multissistêmica inflamatória pediátrica associada ao SARS-CoV-2: uma revisão narrativa: Braz. J. of Develop., Curitiba, v. 6, n.12, p. 101614-101629, dec. 2020.